Tracks long-term outcomes of drug-coated balloon heart procedures in adults
Records long-term results of drug-coated balloon treatment in adults with coronary artery disease.
Plain-language title generated from the registry record
Registry title: ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
Key facts
- Where
- Atlanta, Boston, Charlotte, Cleveland, Durham, Fort Lauderdale, Johns Creek, Minneapolis, Nashville, New York, Phoenix, and Roslyn, United StatesSee the 17 sites
Where in United States
- Emory Saint Joseph's HospitalAtlanta, United StatesTaking people
- Emory University HospitalAtlanta, United StatesTaking people
- Emory University Hospital MidtownAtlanta, United StatesTaking people
- Brigham and Women's HospitalBoston, United StatesNot yet recruiting
- Tufts Medical CenterBoston, United StatesNot yet recruiting
- Sanger Heart & Vascular InstituteCharlotte, United StatesNot yet recruiting
- University Hospitals Cleveland Medical Center*Cleveland, United StatesNot yet recruiting
- Duke University HospitalDurham, United StatesNot yet recruiting
- Holy Cross Health Fort LauderdaleFort Lauderdale, United StatesNot yet recruiting
- Emory Johns Creek HospitalJohns Creek, United StatesTaking people
- Allina Health Minneapolis Heart InstituteMinneapolis, United StatesNot yet recruiting
- Vanderbilt University Medical CenterNashville, United StatesNot yet recruiting
- Montefiore Medical CenterNew York, United StatesNot yet recruiting
- New York - Presbyterian - Weill Cornell Medical CenterNew York, United StatesNot yet recruiting
- The Mount Sinai HospitalNew York, United StatesNot yet recruiting
- Banner University Medical CenterPhoenix, United StatesNot yet recruiting
- St. Francis Hospital & Heart CenterRoslyn, United StatesNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Emory University
- Trial code
- NCT07559903
- Record updated
- 5 October 2026
- Original description
The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.Read full original descriptionShow less
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
Inclusion: All adult patients (≥ 18 years of age) undergoing PCI for de novo CAD using DCB.
Exclusion: Patients under the age of 18; PCI procedures without the utilization of DCB; PCI procedures for non de novo lesions.